Imaging characteristics of phosphaturic mesenchymal tumors

被引:3
|
作者
Gupta, Amit [1 ]
Kandasamy, Devasenathipathy [1 ,5 ]
Sharma, Raju [1 ]
Damle, Nishikant [2 ]
Goyal, Ankur [1 ]
Goyal, Alpesh [3 ]
Agarwal, Shipra [4 ]
Dharmashaktu, Yamini [2 ]
机构
[1] All India Inst Med Sci, Dept Radiodiag & Intervent Radiol, New Delhi, India
[2] All India Inst Med Sci, Dept Nucl Med, New Delhi, India
[3] All India Inst Med Sci, Dept Endocrinol, New Delhi, India
[4] All India Inst Med Sci, Dept Pathol, New Delhi, India
[5] All India Inst Med Sci, Dept Radiodiag & Intervent Radiol, New Delhi 110029, India
关键词
Oncogenic osteomalacia; oncology; imaging; fibroblast growth factor; phosphaturic mesenchymal tumors; INDUCED OSTEOMALACIA; ONCOGENIC OSTEOMALACIA; LOCALIZATION;
D O I
10.1177/02841851231160086
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome associated with phosphaturic mesenchymal tumors (PMTs). Localization of the causative tumor in these cases is an arduous task since the culprit lesions are usually small, slow-growing, and can be located almost anywhere from head to toe. Purpose To describe the morphological characteristics of histologically proven PMTs on various radiological modalities. Material and Methods After institutional ethical approval, this retrospective study analyzed 20 cases with a histopathological evidence of PMT. Various imaging characteristics of the tumors on available computed tomography (CT) and magnetic resonance imaging (MRI) scans were evaluated. Descriptive statistical analyses were conducted. Results The tumors were located in diverse locations: lower extremities (n = 10); head and neck (n = 5); vertebral column (n = 3); pelvis (n = 1); and upper extremities (n = 1). Bone lesions seen on CT had variable morphology: sclerotic (n = 3/8, 37.5%); lytic (n = 3/8, 37.5%), and both lytic and sclerotic (n = 2/8, 25%) with presence of narrow zone of transition in all cases (n = 8/8) and amorphous internal matrix calcifications in 25% of cases (n = 2/8). Of the tumors, 68.4% (n = 13/19) were hypointense on T1 and all of them showed hyperintense signal on T2-weighted and STIR images (n = 19/19) and contrast enhancement (n = 16/16). Of the tumors, 66.7% (n = 6/9) showed restricted diffusion. DOTANOC PET/CT showed tumor uptake in all cases (n = 8/8). Conclusion PMTs may have variable and non-specific tumor appearances on various imaging modalities. However, in an appropriate clinical scenario and a background of suggestive biochemical work-up, the radiologist should keep a high index of suspicion.
引用
收藏
页码:2061 / 2073
页数:13
相关论文
共 50 条
  • [21] PHOSPHATURIC MESENCHYMAL TUMORS - A POLYMORPHOUS GROUP CAUSING OSTEOMALACIA RICKETS
    WEIDNER, N
    CRUZ, DS
    LABORATORY INVESTIGATION, 1987, 56 (01) : A85 - A85
  • [22] Phosphaturic Mesenchymal Tumors: Rethinking the Clinical Diagnosis and Surgical Treatment
    Liu, Yupeng
    He, Hongbo
    Zhang, Can
    Zeng, Hao
    Tong, Xiaopeng
    Liu, Qing
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [23] Most phosphaturic mesenchymal tumors are a single entity: An analysis of 31 cases
    Folpe, AL
    Fanburg-Smith, JC
    Weiss, SW
    MODERN PATHOLOGY, 2003, 16 (01) : 12A - 12A
  • [24] Intracranial phosphaturic mesenchymal tumors. A case report and review of literature
    Kojima, Daijiro
    Ohba, Shigeo
    Abe, Masato
    Suzuki, Atsushi
    Horibe, Seiji
    Tateya, Ichiro
    Hasegawa, Mitsuhiro
    Hirose, Yuichi
    NEUROPATHOLOGY, 2022, 42 (05) : 453 - 458
  • [25] Phosphaturic Mesenchymal Tumor
    Benson, J. C.
    Trejo-Lopez, J. A.
    Nassiri, A. M.
    Eschbacher, K.
    Link, M. J.
    Driscoll, C. L.
    Tiegs, R. D.
    Sfeir, J.
    DeLone, D. R.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2022, 43 (06) : 817 - 822
  • [26] Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors
    Li, Dongmei
    Zhu, Ran
    Zhou, Lian
    Zhong, Dingrong
    MEDICINE, 2020, 99 (07)
  • [27] Most phosphaturic mesenchymal tumors are a single entity: An analysis of 31 cases
    Folpe, AL
    Fanburg-Smith, JC
    Weiss, SW
    LABORATORY INVESTIGATION, 2003, 83 (01) : 12A - 12A
  • [28] Surgical Treatment and Outcomes for Sinonasal and Skull Base Phosphaturic Mesenchymal Tumors
    Tang, Ru
    Mao, Song
    Lin, Hai
    Ye, Hai-Bo
    Li, Da-Wei
    Chen, Zheng-Nong
    Su, Kai-Ming
    Zhang, Wei-Tian
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 162 (05) : 674 - 682
  • [29] Intracranial Phosphaturic Mesenchymal Tumors: A Systematic Literature Review of a Rare Entity
    Munoz, Raul Sanchez
    Sanmillan, Jose L.
    Sarro, Noemi Vidal
    Quintero, Guillermo Martin
    Duce, Daniel Marti
    Canals, Andreu Gabarroes
    WORLD NEUROSURGERY, 2024, 187 : 70 - 81
  • [30] Phosphaturic Mesenchymal Tumor
    Barrera, Christian A.
    Karp, John
    Kearns, Cilein
    Rhodes, Nicholas G.
    RADIOGRAPHICS, 2023, 43 (01)